Test ID: AGXMS
AGXT Gene, Full Gene Analysis
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
89915
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Confirming a diagnosis of primary hyperoxaluria type 1
Carrier testing for individuals with a family history of primary hyperoxaluria type 1 in the absence of known mutations in the family
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis and Gene Dosage Analysis by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
AGXT Gene, Full Gene Analysis
Aliases Lists additional common names for a test, as an aid in searching
AGXT (Alanine-Glyoxylate Aminotransferase)
Alanine-Glyoxylate Aminotransferase (AGXT)
Hyperoxaluria
PH1 (Primary Hyperoxaluria Type 1)
Primary Hyperoxaluria
Primary Hyperoxaluria Type 1 (PH1)
Alanine-Glyoxylate Aminotransferase (AGXT)
Hyperoxaluria
PH1 (Primary Hyperoxaluria Type 1)
Primary Hyperoxaluria
Primary Hyperoxaluria Type 1 (PH1)
External
link
PDF
document
Excel
document
Word
document